Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fred J. Hess
Observed names:
F Hess,
Fred Hess
Institution:
Merck & Co., Inc., Rahway, NJ, USA (United States)
Observed institution:
Merck & Co., Inc., Rahway, NJ, USA (United States)
OpenAlex ID:
A5046973074
LDL-receptor-related proteins in Wnt signal transduction
2000
·
Keiko Tamai
, Mikhail Semenov
, et al.
·
Nature
·
1,515
Discovery of 6-(Fluoro- 18 F )-3-(1 H -pyrrolo[2,3- c ]pyridin-1-yl)isoquinolin-5-amine ([ 18 F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)
2016
·
Abbas M. Walji
, Eric D. Hostetler
, et al.
·
Journal of Medicinal Chemistry
·
204
Salt-Sensitive Hypertension in Bradykinin B2Receptor Knockout Mice
1996
·
Marcos E. Alfie
, Xiao-Ping Yang
, et al.
·
Biochemical and Biophysical Research Communications
·
135
Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors
2011
·
Jens Brodbeck
, Jim McGuire
, et al.
·
Journal of Biological Chemistry
·
125
PDF
Effects of the bradykinin B1 receptor antagonist des-Arg9[Leu8]bradykinin and genetic disruption of the B2 receptor on nociception in rats and mice
1997
·
Nadia M.J Rupniak
, Susan Boyce
, et al.
·
Pain
·
122
A Potent and Selective Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator Improves Movement in Rodent Models of Parkinson's Disease
2012
·
Emmanuel Le Poul
, Christelle Boléa
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
110
Insights into activity and inhibition from the crystal structure of human O-GlcNAcase
2017
·
Nathaniel L Elsen
, Sangita B Patel
, et al.
·
Nature Chemical Biology
·
96
Discovery of a Potent, Non-peptide Bradykinin B1 Receptor Antagonist
2003
·
Dai-Shi Su
, M. Kristine Markowitz
, et al.
·
Journal of the American Chemical Society
·
92
Pharmacology of kinins in the arterial and venous mesenteric bed of normal and B2 knockout transgenic mice
1997
·
Nathalie Berthiaume
, Fred Hess
, et al.
·
European Journal of Pharmacology
·
36
O2‐13‐04: Early Clinical Results and Preclinical Validation of the O‐Glcnacase (OGA) Inhibitor Mk‐8719 as a Novel Therapeutic for the Treatment of Tauopathies
2016
·
Sean M. Smith
, Arie Struyk
, et al.
·
Alzheimer s & Dementia
·
28
Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1
2005
·
Sookhee N. Ha
, Pat J. Hey
, et al.
·
Biochemical and Biophysical Research Communications
·
23
Immunoreactive B1 receptors in human transbronchial tissue
1996
·
Raj Nadar
, Amanda Derrick
, et al.
·
Immunopharmacology
·
20
PISA, A novel pharmacodynamic assay for assessing poly(ADP-ribose) polymerase (PARP) activity in situ
2010
·
Laura S. Lubbers
, Blake A. Rowe
, et al.
·
Journal of Pharmacological and Toxicological Methods
·
2
[The pathogenic effect of human immunodeficiency virus. Molecular biological results].
1989
·
L Gürtler
, F Hess
·
PubMed
·
1
P3‐066: A Cellular Expression Model of TAU Hyperphosphorylation and Aggregation That does not Utilize Frontotemporal Dementia Mutations
2016
·
Joel B. Schachter
, Mali Cosden
, et al.
·
Alzheimer s & Dementia
P3‐073: Intervention of TAU Pathology Prevents Behavioral Changes in RTG4510 Mouse Model of Tauopathy
2016
·
Xiaohai Wang
, Karen Smith
, et al.
·
Alzheimer s & Dementia
Show more works
View as search
Works count:
16
Citation count:
2,505
H-index:
12
I10-index:
12
Year
Topic
Type